Daniel R. Chevallard, Chief Financial Officer at LENZ Therapeutics, Inc. (LENZ), bought 2,198 shares at $22.76 ($50K) on 2025-11-07, disclosed to the SEC on 2025-11-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.71 | 20 | $454 | 0.9% |
| 2 | $22.76 | 2,178 | $50K | 99.1% |
| Total | $22.76 avg | 2,198 | $50K | 100% |
| Filing → |
| VIRX | SELL | 2024-02-27 | $2K | — | Filing → |
| VIRX | SELL | 2023-11-28 | $2K | — | Filing → |
| VIRX | SELL | 2023-08-29 | $5K | — | Filing → |